These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 25240539)

  • 21. DESolve novolimus-eluting bioresorbable coronary scaffold failure assessed by frequency-domain optical coherence tomography imaging.
    Porto I; Vergallo R; Sangiorgi GM; Burzotta F; Garbo R; D'Amario D; Trani C; Rebuzzi AG; Crea F
    Coron Artery Dis; 2016 Jun; 27(4):334-6. PubMed ID: 26882020
    [No Abstract]   [Full Text] [Related]  

  • 22. Optical coherence tomography evaluation of the absorb bioresorbable scaffold performance for overlap versus non-overlap segments in patients with coronary chronic total occlusion: insight from the GHOST-CTO registry.
    Pereira GTR; La Manna A; Ichibori Y; Vergara-Martel A; Ramos Nascimento B; Samdani AJ; Capodanno D; D'Agosta G; Gravina G; Venuti G; Tamburino C; F Attizzani G
    Int J Cardiovasc Imaging; 2019 Oct; 35(10):1767-1776. PubMed ID: 31175527
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Recanalized thrombus treated with bioresorbable vascular scaffold: insights from optical coherence tomography.
    Gómez-Monterrosas O; Regueiro A; Santos A; Otsuki S; Scalone G; Fernández-Rodríguez D; Sabaté M
    JACC Cardiovasc Interv; 2014 Dec; 7(12):1453-5. PubMed ID: 25457058
    [No Abstract]   [Full Text] [Related]  

  • 24. First reported use of drug-coated balloon for bioresorbable in-scaffold restenosis.
    Latini RA; Buccheri D; Cortese B
    Catheter Cardiovasc Interv; 2017 Mar; 89(4):676-678. PubMed ID: 27649683
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Novel ultrahigh molecular weight amorphous PLLA bioresorbable coronary scaffold upsized up to 0.8 mm beyond nominal diameter: An OCT and histopathology study in porcine coronary artery model.
    Gasior P; Cheng Y; Estrada EA; Jenn McGregor ; Ramzipoor K; Lee C; Conditt GB; Rousselle SD; Granada JF; Kaluza GL
    Catheter Cardiovasc Interv; 2018 Feb; 91(3):378-386. PubMed ID: 28471065
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Fate of Coronary Chronic Total Occlusion Recanalization via Subintimal Tracking With Bioresorbable Vascular Scaffolds: A Temporary Cage for a Permanent New Lumen?
    La Manna A; Ohno Y; Attizzani GF; Chisari A; Giacchi G; Capodanno D; Tamburino C
    JACC Cardiovasc Imaging; 2015 Sep; 8(9):1114-1115. PubMed ID: 25577443
    [No Abstract]   [Full Text] [Related]  

  • 27. Culotte Technique With a Bioresorbable Vascular Scaffold: 12 Months' Follow-up.
    Vera Pernasetti L; Gutiérrez H; Ramos B
    Rev Esp Cardiol (Engl Ed); 2016 Oct; 69(10):973-974. PubMed ID: 27085839
    [No Abstract]   [Full Text] [Related]  

  • 28. Optical coherence tomography for guiding wire into a side branch coronary artery with flush total occlusion.
    Qureshi YH; Weisz G; Maehara A; Hakim DA; Fall K; Castaneda A; Moses JW
    Cardiovasc Revasc Med; 2015; 16(1):55-7. PubMed ID: 25081229
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Disruption of bioresorbable vascular scaffold struts due to loss of radial integrity: insights from optical coherence tomography.
    Ramalho AR; Silva Marques J; Mariano Pêgo G
    Int J Cardiovasc Imaging; 2017 Mar; 33(3):311-312. PubMed ID: 27832420
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Bioresorption and Vessel Wall Integration of a Fully Bioresorbable Polymeric Everolimus-Eluting Scaffold: Optical Coherence Tomography, Intravascular Ultrasound, and Histological Study in a Porcine Model With 4-Year Follow-Up.
    Nakatani S; Ishibashi Y; Sotomi Y; Perkins L; Eggermont J; Grundeken MJ; Dijkstra J; Rapoza R; Virmani R; Serruys PW; Onuma Y
    JACC Cardiovasc Interv; 2016 Apr; 9(8):838-851. PubMed ID: 27101910
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bioresorbable scaffolds for treatment of coronary bifurcation lesions: Critical appraisal and future perspectives.
    Diletti R; Tchetche D; Barbato E; Latib A; Farah B; van Geuns RJ; Colombo A; Fajadet J; van Mieghem NM
    Catheter Cardiovasc Interv; 2016 Sep; 88(3):397-406. PubMed ID: 27143281
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Feasibility and efficacy of bioresorbable vascular scaffolds use for the treatment of in-stent restenosis and a bifurcation lesion in a heavily calcified diffusely diseased vessel.
    Naganuma T; Costopoulos C; Latib A; Sato K; Miyazaki T; Colombo A
    JACC Cardiovasc Interv; 2014 May; 7(5):e45-6. PubMed ID: 24746654
    [No Abstract]   [Full Text] [Related]  

  • 33. Drug-coated balloon without stent implantation for chronic total occlusion of coronary arteries: Description of a new strategy with an optical coherence tomography assistance.
    Cortese B; Buccheri D; Piraino D; Silva-Orrego P
    Int J Cardiol; 2015 Jul; 191():75-6. PubMed ID: 25965604
    [No Abstract]   [Full Text] [Related]  

  • 34. Coronary bifurcation lesions: Some questions need an answer to make bioresorbable vascular scaffold technology more "coronary bifurcation-friendly".
    Piraino D; Buccheri D; Andolina G
    Int J Cardiol; 2016 Jul; 215():80-3. PubMed ID: 27111164
    [No Abstract]   [Full Text] [Related]  

  • 35. Modified T-technique with bioresorbable scaffolds ensures complete carina coverage: an optical coherence tomography study.
    van Mieghem N; Wilschut JJ; Ligthart J; Witberg K; van Geuns RJ; Regar E
    JACC Cardiovasc Interv; 2014 Aug; 7(8):e109-10. PubMed ID: 25086845
    [No Abstract]   [Full Text] [Related]  

  • 36. The duration of balloon inflation affects the luminal diameter of coronary segments after bioresorbable vascular scaffolds deployment.
    Sorrentino S; De Rosa S; Ambrosio G; Mongiardo A; Spaccarotella C; Polimeni A; Sabatino J; Torella D; Caiazzo G; Indolfi C
    BMC Cardiovasc Disord; 2015 Dec; 15():169. PubMed ID: 26654975
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Treading the risky ground of coronary bifurcation lesion revascularization, the "biodegradable strategy" may represent the lifeline.
    Piraino D; Buccheri D; Andolina G
    Int J Cardiol; 2016 Oct; 221():577-80. PubMed ID: 27420582
    [No Abstract]   [Full Text] [Related]  

  • 38. Migrated remnant bioresorbable scaffolds in a left main bifurcation lesion: Insights from optical coherence tomography.
    Seo J; Kim Y; Kim BK; Hong SJ; Ahn CM; Kim JS; Cho DK; Ko YG; Choi D; Hong MK; Jang Y
    Cardiol J; 2020; 27(2):208-209. PubMed ID: 32463107
    [No Abstract]   [Full Text] [Related]  

  • 39. Edge vascular response after percutaneous coronary intervention: an intracoronary ultrasound and optical coherence tomography appraisal: from radioactive platforms to first- and second-generation drug-eluting stents and bioresorbable scaffolds.
    Gogas BD; Garcia-Garcia HM; Onuma Y; Muramatsu T; Farooq V; Bourantas CV; Serruys PW
    JACC Cardiovasc Interv; 2013 Mar; 6(3):211-21. PubMed ID: 23517830
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Stent loss during chronic total occlusion percutaneous coronary intervention: Optical coherence tomography-guided stent 'crushing and trapping'.
    Candilio L; Mitomo S; Carlino M; Colombo A; Azzalini L
    Cardiovasc Revasc Med; 2017; 18(7):531-534. PubMed ID: 28351604
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.